Test Price
2,800 AED✅ Home Collection Available
TTN Gene Cardiomyopathy, Familial Hypertrophic Type 9 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-Certified Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Clinical Summary: The TTN (Titin) gene NGS test identifies pathogenic variants causing familial hypertrophic cardiomyopathy type 9 (CMH9) and related cardiovascular disorders. It provides a definitive molecular diagnosis to guide clinical management, risk stratification for first-degree relatives, and life-saving preventive interventions in asymptomatic carriers.
| Parameter | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Precision | NGS with full gene sequencing and CNV analysis (99.9% sensitivity) | Targeted panel (may miss deep intronic or large rearrangements) |
| Methodology | Illumina NovaSeq™ S4 NGS with MLPA/CGH confirmation | Older Sanger sequencing or limited exome panels |
| Turnaround Time | Industry-leading 3–4 Weeks | Often 6–8 Weeks |
| Home Collection | ISO Cold-Chain Home Collection (8 AM–11 PM) | May require hospital visit |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA: 9294403): "A positive TTN variant result is not a definitive sentence; it is a critical data point that must be interpreted alongside comprehensive cardiac imaging, family history, and ECG patterns. Genetic information empowers precise risk stratification but never substitutes for clinical judgment. Our team guides your entire cardiology and genetics care pathway through result interpretation."
Medication Advisory
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. No changes to current treatment should be made solely based on genetic test results without specialist review.
Safety & Exclusion Criteria
- Pregnancy or breastfeeding (genetic test remains safe but clinical decisions may differ).
- Severe anemia precluding blood draw – confirm with phlebotomist.
- ER Red Flags: Chest pain, syncope, severe shortness of breath, or palpitations with dizziness – go to nearest emergency department immediately before test.
Patient FAQ & Clinical Guidance
1. How does the TTN gene test detect familial hypertrophic cardiomyopathy type 9?
Snippet: The test uses Next Generation Sequencing (NGS) to analyze the entire TTN gene for mutations that cause familial hypertrophic cardiomyopathy type 9 with 99.9% sensitivity.
2. What do I need to do before the home blood collection appointment?
Snippet: Prior to the home collection, you must complete a genetic counseling session and a detailed clinical history, avoiding heparin-based blood thinners for 24 hours.
3. How reliable are these results for my family members?
Snippet: A positive result confirms a 50% inheritance risk for each first-degree relative, enabling cascade testing to identify at-risk individuals before symptoms appear.
UAE Regulatory & Data Privacy Adherence
- This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical safety and patient consent standards follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139), DHA Facility License: 1143.
- Call or WhatsApp +971 54 548 8731 for booking or inquiries.
Clinical & Logistical Metadata
| Test Name | TTN Gene Cardiomyopathy, Familial Hypertrophic Type 9 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | NGS (Next Generation Sequencing) with MLPA/CGH confirmation |
| ICD-10-CM Code | I42.2 |
| LOINC Code | 92814-2 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians